Skip to main content
Top
Published in: Diabetologia 4/2018

Open Access 01-04-2018 | Article

The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes

Authors: Paul Z. Benitez-Aguirre, Tien Y. Wong, Maria E. Craig, Elizabeth A. Davis, Andrew Cotterill, Jennifer J. Couper, Fergus J. Cameron, Farid H. Mahmud, Tim W. Jones, Lauren A. B. Hodgson, R. Neil Dalton, David B. Dunger, Kim C. Donaghue, The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)

Published in: Diabetologia | Issue 4/2018

Login to get access

Abstract

Aims/hypothesis

We examined the hypothesis that elevation in urinary albumin creatinine ratio (ACR) in adolescents with type 1 diabetes is associated with abnormal retinal vascular geometry (RVG) phenotypes.

Methods

A cross-sectional study at baseline of the relationship between ACR within the normoalbuminuric range and RVG in 963 adolescents aged 14.4 ± 1.6 years with type 1 diabetes (median duration 6.5 years) screened for participation in AdDIT. A validated algorithm was used to categorise log10 ACR into tertiles: upper tertile ACR was defined as ‘high-risk’ for future albuminuria and the lower two tertiles were deemed ‘low-risk’. RVG analysis, using a semi-automated computer program, determined retinal vascular calibres (standard and extended zones) and tortuosity. RVG measures were analysed continuously and categorically (in quintiles: Q1–Q5) for associations with log10 ACR and ACR risk groups.

Results

Greater log10 ACR was associated with narrower vessel calibres and greater tortuosity. The high-risk group was more likely to have extended zone vessel calibres in the lowest quintile (arteriolar Q1 vs Q2–Q5: OR 1.67 [95% CI 1.17, 2.38] and venular OR 1.39 [0.98, 1.99]) and tortuosity in the highest quintile (Q5 vs Q1–Q4: arteriolar OR 2.05 [1.44, 2.92] and venular OR 2.38 [1.67, 3.40]). The effects of retinal vascular calibres and tortuosity were additive such that the participants with the narrowest and most tortuous vessels were more likely to be in the high-risk group (OR 3.32 [1.84, 5.96]). These effects were independent of duration, blood pressure, BMI and blood glucose control.

Conclusions/interpretation

Higher ACR in adolescents is associated with narrower and more tortuous retinal vessels. Therefore, RVG phenotypes may serve to identify populations at high risk of diabetes complications during adolescence and well before onset of clinical diabetes complications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Karalliedde J, Viberti G (2005) Hypertension and microalbuminuria: risk factors for cardiovascular disease in diabetes. Curr Hypertens Rep 7:1–2CrossRefPubMed Karalliedde J, Viberti G (2005) Hypertension and microalbuminuria: risk factors for cardiovascular disease in diabetes. Curr Hypertens Rep 7:1–2CrossRefPubMed
2.
go back to reference Lacquaniti A, Donato V, Pintaudi B et al (2013) ʻNormoalbuminuricʼ diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 50:935–942CrossRefPubMed Lacquaniti A, Donato V, Pintaudi B et al (2013) ʻNormoalbuminuricʼ diabetic nephropathy: tubular damage and NGAL. Acta Diabetol 50:935–942CrossRefPubMed
3.
go back to reference Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV (2013) Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complicat 27:123–127CrossRefPubMed Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV (2013) Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complicat 27:123–127CrossRefPubMed
4.
go back to reference Molitch ME, Steffes M, Sun W et al (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33:1536–1543CrossRefPubMedPubMedCentral Molitch ME, Steffes M, Sun W et al (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 33:1536–1543CrossRefPubMedPubMedCentral
5.
go back to reference Cho YH, Craig ME, Donaghue KC (2014) Puberty as an accelerator for diabetes complications. Pediatr Diabetes 15:18–26CrossRefPubMed Cho YH, Craig ME, Donaghue KC (2014) Puberty as an accelerator for diabetes complications. Pediatr Diabetes 15:18–26CrossRefPubMed
6.
go back to reference Dunger DB (1992) Diabetes in puberty. Arch Dis Child 67:569–570 Dunger DB (1992) Diabetes in puberty. Arch Dis Child 67:569–570
7.
go back to reference Klein R, Knudtson MD, Klein BE et al (2010) The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes. Diabetologia 53:1638–1646CrossRefPubMedPubMedCentral Klein R, Knudtson MD, Klein BE et al (2010) The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes. Diabetologia 53:1638–1646CrossRefPubMedPubMedCentral
8.
go back to reference Velayutham V, Benitez-Aguirre PZ, Craig ME et al (2017) Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes. Diabetologia 60:2103–2110CrossRefPubMed Velayutham V, Benitez-Aguirre PZ, Craig ME et al (2017) Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes. Diabetologia 60:2103–2110CrossRefPubMed
9.
10.
go back to reference Boright AP, Paterson AD, Mirea L et al (2005) Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 54:1238–1244CrossRefPubMedPubMedCentral Boright AP, Paterson AD, Mirea L et al (2005) Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 54:1238–1244CrossRefPubMedPubMedCentral
11.
go back to reference Marcovecchio ML, Woodside J, Jones T et al (2014) Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 37:805–813CrossRefPubMed Marcovecchio ML, Woodside J, Jones T et al (2014) Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 37:805–813CrossRefPubMed
12.
go back to reference The Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group (2009) Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC pediatrics 9: 79 The Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group (2009) Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC pediatrics 9: 79
13.
14.
go back to reference Dunger DB, Schwarze CP, Cooper JD et al (2007) Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 24:131–136CrossRefPubMed Dunger DB, Schwarze CP, Cooper JD et al (2007) Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabet Med 24:131–136CrossRefPubMed
15.
go back to reference Amin R, Widmer B, Prevost AT et al (2008) Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 336:697–701CrossRefPubMedPubMedCentral Amin R, Widmer B, Prevost AT et al (2008) Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 336:697–701CrossRefPubMedPubMedCentral
16.
go back to reference Cherney DZ, Sochett EB (2011) Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes. Diabetes Care 34:1821–1826CrossRefPubMedPubMedCentral Cherney DZ, Sochett EB (2011) Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes. Diabetes Care 34:1821–1826CrossRefPubMedPubMedCentral
17.
go back to reference Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319CrossRefPubMed
18.
go back to reference Task Force on Blood Pressure Control in Children (1987) Report of the Second Task Force on Blood Pressure Control in Children--1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 79:1–25 Task Force on Blood Pressure Control in Children (1987) Report of the Second Task Force on Blood Pressure Control in Children--1987. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 79:1–25
19.
go back to reference McGeechan K, Liew G, Macaskill P et al (2008) Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 102:58–63CrossRefPubMedPubMedCentral McGeechan K, Liew G, Macaskill P et al (2008) Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol 102:58–63CrossRefPubMedPubMedCentral
20.
go back to reference Roy MS, Klein R, Janal MN (2012) Relationship of retinal vessel caliber to cardiovascular disease and mortality in African Americans with type 1 diabetes mellitus. Arch Ophthalmol 130:561–567CrossRefPubMed Roy MS, Klein R, Janal MN (2012) Relationship of retinal vessel caliber to cardiovascular disease and mortality in African Americans with type 1 diabetes mellitus. Arch Ophthalmol 130:561–567CrossRefPubMed
21.
go back to reference Ding J, Wai KL, McGeechan K et al (2014) Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens 32:207–215CrossRefPubMedPubMedCentral Ding J, Wai KL, McGeechan K et al (2014) Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data. J Hypertens 32:207–215CrossRefPubMedPubMedCentral
22.
go back to reference McGahon MK, Dash DP, Arora A et al (2007) Diabetes downregulates large-conductance Ca2+-activated potassium β1 channel subunit in retinal arteriolar smooth muscle. Circ Res 100:703–711CrossRefPubMedPubMedCentral McGahon MK, Dash DP, Arora A et al (2007) Diabetes downregulates large-conductance Ca2+-activated potassium β1 channel subunit in retinal arteriolar smooth muscle. Circ Res 100:703–711CrossRefPubMedPubMedCentral
23.
go back to reference Al-Kateb H, Boright AP, Mirea L et al (2008) Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 57:218–228CrossRefPubMed Al-Kateb H, Boright AP, Mirea L et al (2008) Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes 57:218–228CrossRefPubMed
24.
go back to reference Benitez-Aguirre P, Craig ME, Sasongko MB et al (2011) Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care 34:1622–1627CrossRefPubMedPubMedCentral Benitez-Aguirre P, Craig ME, Sasongko MB et al (2011) Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence. Diabetes Care 34:1622–1627CrossRefPubMedPubMedCentral
25.
go back to reference Benitez-Aguirre PZ, Sasongko BM, Craig M et al (2012) Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care 35:599–604CrossRefPubMedPubMedCentral Benitez-Aguirre PZ, Sasongko BM, Craig M et al (2012) Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care 35:599–604CrossRefPubMedPubMedCentral
26.
go back to reference Sasongko MB, Wong TY, Donaghue KC et al (2012) Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol 153:176–183 e171CrossRefPubMed Sasongko MB, Wong TY, Donaghue KC et al (2012) Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol 153:176–183 e171CrossRefPubMed
27.
go back to reference Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M (2002) Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet Med 19:212–215CrossRefPubMed Kao Y, Donaghue KC, Chan A, Bennetts BH, Knight J, Silink M (2002) Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes. Diabet Med 19:212–215CrossRefPubMed
Metadata
Title
The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes
Authors
Paul Z. Benitez-Aguirre
Tien Y. Wong
Maria E. Craig
Elizabeth A. Davis
Andrew Cotterill
Jennifer J. Couper
Fergus J. Cameron
Farid H. Mahmud
Tim W. Jones
Lauren A. B. Hodgson
R. Neil Dalton
David B. Dunger
Kim C. Donaghue
The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 4/2018
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4538-2

Other articles of this Issue 4/2018

Diabetologia 4/2018 Go to the issue

Up Front

Up front

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.